Jacob Schlossman

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Incidence, molecular characteristics, and imaging features of “clinically-defined pseudoprogression” in newly diagnosed glioblastoma treated with chemoradiation”.

Incidence, molecular characteristics, and imaging features of “clinically-defined pseudoprogression” in newly diagnosed glioblastoma treated with chemoradiation

Journal of Neuro-Oncology(2022)10.1007/s11060-022-04088-3

N/A

0.782DataRank · unranked

16 citations

Jacob Schlossman, Soroush Shabani, Catalina Raymond, Hiroyuki Tatekawa, Lauren E. Abrey +10 more

Rate of change in maximum 18F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomas

Journal of Neuro-Oncology(2020)10.1007/s11060-020-03407-w

N/A

0.442DataRank · unranked

18 citations

Jingwen Yao, Jacob Schlossman, Catalina Raymond, Matthew Ji, Hiroyuki Tatekawa +8 more

Estimated clinical efficacy and radiographic response characteristics of PD1 inhibition in newly diagnosed and recurrent glioblastoma in clinical practice: A report from the iRANO Working Group.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2521

N/A

0.241DataRank · unranked

4 citations

Raymond Y. Huang, Javier Villanueva‐Meyer, Mary Jane Lim-Fat, Elizabeth George, Bryan Iorgulescu +13 more

Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor Burden

Neurosurgery(2020)10.1093/neuros/nyaa135

N/A

0DataRank · unranked

22 citations

Richard G. Everson, Jingwen Yao, Catalina Raymond, J.W. Goldman, Jacob Schlossman +11 more

Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors

Neuro-Oncology(2021)10.1093/neuonc/noab276

N/A

0DataRank · unranked

26 citations

Talia C. Oughourlian, Nicholas S. Cho, Jacob Schlossman, Chencai Wang, Jingwen Yao +13 more